世界の製薬産業用フレキシブル生産システム市場2021年-2031年:製品タイプ別(モジュール製造、データ駆動型製造、シングルユース製造、連続製造)、技術別、産業別

【英語タイトル】Flexible Manufacturing Systems for Pharmaceutical Industry Market By Product Type (Modular manufacturing, Data-driven manufacturing, Single-use manufacturing, Continuous manufacturing), By Technology (Hardware, Software), By End User Industry (Large Pharmaceutical Manufacturers, Medium and Small Pharmaceutical Manufacturers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが出版した調査資料(ALD22NV0278)・商品コード:ALD22NV0278
・発行会社(調査会社):Allied Market Research
・発行日:2022年8月
・ページ数:310
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:物流
◆販売価格オプション(消費税別)
Single UserUSD5,730 ⇒換算¥848,040見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD9,600 ⇒換算¥1,420,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社の本調査資料では、世界の製薬産業用フレキシブル生産システム市場規模が2021年1,962.2百万ドルから2031年3,319.7百万ドルに達し、2022年から2031年まで年平均5.3%成長すると予測しています。当書は、製薬産業用フレキシブル生産システムの世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、製品タイプ別(モジュール製造、データ駆動型製造、シングルユース製造、連続製造)分析、技術別(ハードウェア、ソフトウェア)分析、産業別(大手製薬メーカー、中堅・中小製薬メーカー)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、Angstrom Technology、Biologics Modular, LLC、Chempharm、Cytiva、ESC (Environmental Systems Corporation)、Exyte GmbH、G-CON Manufacturing、Germfree Laboratories Inc.、IPM Technologies、KeyPlants Ab、などが含まれております。
・イントロダクション
・エグゼクティブサマリー
・市場概要

・世界の製薬産業用フレキシブル生産システム市場規模:製品タイプ別
- モジュール製造の市場規模
- データ駆動型製造の市場規模
- シングルユース製造の市場規模
- 連続製造の市場規模

・世界の製薬産業用フレキシブル生産システム市場規模:技術別
- ハードウェア技術の市場規模
- ソフトウェア技術の市場規模

・世界の製薬産業用フレキシブル生産システム市場規模:産業別
- 大手製薬メーカーにおける市場規模
- 中堅・中小製薬メーカーにおける市場規模

・世界の製薬産業用フレキシブル生産システム市場規模:地域別
- 北米の製薬産業用フレキシブル生産システム市場規模
- ヨーロッパの製薬産業用フレキシブル生産システム市場規模
- アジア太平洋の製薬産業用フレキシブル生産システム市場規模
- 中南米の製薬産業用フレキシブル生産システム市場規模
- 中東/アフリカの製薬産業用フレキシブル生産システム市場規模

・企業状況
・企業情報

The global flexible manufacturing systems for pharmaceutical industry size was valued at $1,962.2 million in 2021 and is projected to reach $3,319.7 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.

A flexible manufacturing system for pharmaceuticals is a system that includes specialized machineries, processes, and operations involved in pharmaceutical manufacturing that are capable of being modified and changed within a short span of time to cope  with sudden market changes.
Government and private agencies across the world keep a close eye on the pharmaceutical industry owing to its inherent nature of being associated with the lives of people and animals. Moreover, it is one of the few industries that is highly affected by politics across the world. Along with this, diseases evolve and often develop immunity to medicines. Such factors drive the demand for flexible manufacturing systems for pharmaceutical industry, as they allow quick response to market changes.
Increase in number of patients suffering from diseases such as heart diseases, diabetes, and arthritis rare diseases has significantly increased owing to rise in geriatric population. Furthermore, rise in number of patients has increased the demand for in pharmaceutical industry. These factors positively influence the growth of the flexible manufacturing systems for pharmaceutical industry. However, requirement for highly skilled professionals for operating and developing flexible manufacturing systems for pharmaceutical is a major restraint in the industry. Furthermore, rise in pharmaceutical industry in the emerging nations provides lucrative growth opportunities for the industry.
The global flexible manufacturing systems for pharmaceutical industry is segmented on the basis of type, technology, end user, and region. By type, the market is categorized into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing. On the basis of technology, it is segmented into software and hardware. By end user, it is bifurcated into large pharmaceutical manufacturers and medium & small pharmaceutical manufacturers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global market have adopted key strategies such as product launch, partnership, and acquisition to strengthen their market outreach and sustain the stiff competition in the market.

Competition Analysis 
Key companies profiled in the flexible manufacturing systems for pharmaceutical industry report include Angstrom Technology, Biologics Modular, LLC, Chempharm, Cytiva, ESC (Environmental Systems Corporation), Exyte GmbH, G-CON Manufacturing, Germfree Laboratories Inc., IPM Technologies, KeyPlants Ab, ModuleCo Ltd., Modwave LLC, Nicomac Srl, NNE, Pharmadule Morimatsu AB, PR Pharma, and Engineers Pvt. Ltd.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flexible manufacturing systems for pharmaceutical industry market analysis from 2021 to 2031 to identify the prevailing flexible manufacturing systems for pharmaceutical industry market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the flexible manufacturing systems for pharmaceutical industry market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global flexible manufacturing systems for pharmaceutical industry market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type
● Modular manufacturing
● Data-driven manufacturing
● Single-use manufacturing
● Continuous manufacturing

By Technology
● Hardware
● Software

By End User Industry
● Large Pharmaceutical Manufacturers
○ Method
○ Machine Flexibility
○ Volume Flexibility
● Medium and Small Pharmaceutical Manufacturers

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ Italy
○ UK
○ Spain
○ Netherlands
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Indonesia
○ Vietnam
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Argentina
○ Saudi Arabia
○ UAE
○ South Africa
○ Kenya

Key Market Players
○ Angstrom Technology
○ Biologics Modular, LLC
○ Chempharm
○ Cytiva
○ ESC (Environmental Systems Corporation)
○ Exyte GmbH
○ G-CON Manufacturing
○ Germfree Laboratories Inc.
○ IPM Technologies
○ KeyPlants Ab
○ ModuleCo Ltd.
○ Modwave LLC
○ Nicomac Srl
○ NNE
○ Pharmadule Morimatsu AB
○ PR Pharma Engineers Pvt. Ltd.
○ Univercells Technologies

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Modular manufacturing
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Data-driven manufacturing
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Single-use manufacturing
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Continuous manufacturing
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Hardware
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Software
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY
6.1 Overview
6.1.1 Market size and forecast
6.2 Large Pharmaceutical Manufacturers
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.2.4 Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
6.2.4.1 Machine Flexibility Market size and forecast, by region
6.2.4.2 Volume Flexibility Market size and forecast, by region
6.3 Medium and Small Pharmaceutical Manufacturers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End User Industry
7.2.4.1 North America Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End User Industry
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End User Industry
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End User Industry
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User Industry
7.3.4.1 Europe Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End User Industry
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End User Industry
7.3.5.3 Italy
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End User Industry
7.3.5.4 UK
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End User Industry
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End User Industry
7.3.5.6 Netherlands
7.3.5.6.1 Market size and forecast, by Product Type
7.3.5.6.2 Market size and forecast, by Technology
7.3.5.6.3 Market size and forecast, by End User Industry
7.3.5.7 Rest of Europe
7.3.5.7.1 Market size and forecast, by Product Type
7.3.5.7.2 Market size and forecast, by Technology
7.3.5.7.3 Market size and forecast, by End User Industry
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End User Industry
7.4.4.1 Asia-Pacific Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End User Industry
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End User Industry
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End User Industry
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Technology
7.4.5.4.3 Market size and forecast, by End User Industry
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Product Type
7.4.5.5.2 Market size and forecast, by Technology
7.4.5.5.3 Market size and forecast, by End User Industry
7.4.5.6 Indonesia
7.4.5.6.1 Market size and forecast, by Product Type
7.4.5.6.2 Market size and forecast, by Technology
7.4.5.6.3 Market size and forecast, by End User Industry
7.4.5.7 Vietnam
7.4.5.7.1 Market size and forecast, by Product Type
7.4.5.7.2 Market size and forecast, by Technology
7.4.5.7.3 Market size and forecast, by End User Industry
7.4.5.8 Rest of Asia-Pacific
7.4.5.8.1 Market size and forecast, by Product Type
7.4.5.8.2 Market size and forecast, by Technology
7.4.5.8.3 Market size and forecast, by End User Industry
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End User Industry
7.5.4.1 LAMEA Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End User Industry
7.5.5.2 Argentina
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End User Industry
7.5.5.3 Saudi Arabia
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End User Industry
7.5.5.4 UAE
7.5.5.4.1 Market size and forecast, by Product Type
7.5.5.4.2 Market size and forecast, by Technology
7.5.5.4.3 Market size and forecast, by End User Industry
7.5.5.5 South Africa
7.5.5.5.1 Market size and forecast, by Product Type
7.5.5.5.2 Market size and forecast, by Technology
7.5.5.5.3 Market size and forecast, by End User Industry
7.5.5.6 Kenya
7.5.5.6.1 Market size and forecast, by Product Type
7.5.5.6.2 Market size and forecast, by Technology
7.5.5.6.3 Market size and forecast, by End User Industry
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Angstrom Technology
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Biologics Modular, LLC
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Chempharm
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cytiva
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 ESC (Environmental Systems Corporation)
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Exyte GmbH
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 G-CON Manufacturing
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Germfree Laboratories Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 IPM Technologies
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 KeyPlants Ab
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 ModuleCo Ltd.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Modwave LLC
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Nicomac Srl
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 NNE
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Pharmadule Morimatsu AB
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 PR Pharma Engineers Pvt. Ltd.
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Univercells Technologies
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments



★調査レポート[世界の製薬産業用フレキシブル生産システム市場2021年-2031年:製品タイプ別(モジュール製造、データ駆動型製造、シングルユース製造、連続製造)、技術別、産業別] (コード:ALD22NV0278)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の製薬産業用フレキシブル生産システム市場2021年-2031年:製品タイプ別(モジュール製造、データ駆動型製造、シングルユース製造、連続製造)、技術別、産業別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆